Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/23/2003WO2003087161A1 Modified factor viii
10/23/2003WO2003087155A1 Novel protein and dna thereof
10/23/2003WO2003087152A1 Luminescent markers
10/23/2003WO2003087151A1 A sperm polypeptide
10/23/2003WO2003087149A2 Bacillus licheniformis mutant host cell
10/23/2003WO2003087148A2 Bacillus licheniformis mutant host cell
10/23/2003WO2003087146A2 Purified polypeptides from s. aureus, h. pylori and e. coli involved in cellular transport and metabolism
10/23/2003WO2003087145A2 Purified polypeptides involved in quorum sensing
10/23/2003WO2003087144A2 Insecticide proteins from photorabdus luminescens
10/23/2003WO2003087142A2 Bacillus licheniformis mutant host cell
10/23/2003WO2003087134A2 G-protein coupled receptor ligands and methods
10/23/2003WO2003087126A2 Heteroclitic analogs and related methods
10/23/2003WO2003087123A2 Methods and kits for testing mutagenicity
10/23/2003WO2003087115A2 Oligomeric compounds having modified phosphate groups
10/23/2003WO2003087021A2 Nanoparticle delivery systems and methods of use thereof
10/23/2003WO2003086472A1 Drugs to be used in gene therapy for recessively transmitted genetic disease
10/23/2003WO2003086470A2 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/23/2003WO2003086467A1 Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086453A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
10/23/2003WO2003086450A1 Active antiangiogenic therapy
10/23/2003WO2003086446A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003WO2003086444A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003WO2003086431A1 Virally infected plants as a source of insect reppelants/attractents
10/23/2003WO2003086416A1 Combinations of antisense oligonucleotides directed against thymidylate synythase mrna and uses thereof
10/23/2003WO2003086380A1 Ptx3 gene expression suppressing method
10/23/2003WO2003086311A2 Methods for treating tweak-related conditions
10/23/2003WO2003086308A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003WO2003086289A2 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
10/23/2003WO2003086280A2 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003WO2003086277A2 Attenuated gram negative bacteria
10/23/2003WO2003086276A2 Compositions and methods for portal specific gene delivery and treatment of infection
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003086053A1 Plant transformation system
10/23/2003WO2003086052A2 Low allergen plant and animal genotypes
10/23/2003WO2003072812A3 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
10/23/2003WO2003068929A9 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
10/23/2003WO2003060144A3 High fidelity dna polymerase compositions and uses therefor
10/23/2003WO2003057898A3 Methods and materials for modulating p2x2
10/23/2003WO2003057836A3 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003055998A3 Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase
10/23/2003WO2003054193A3 Raf/ras binding compounds
10/23/2003WO2003054182A3 Production of butyrylcholinesterases in transgenic mammals
10/23/2003WO2003050242A3 Dna amplification and sequencing using dna molecules generated by random fragmentation
10/23/2003WO2003049832A8 Extraction and winterization of lipids from oilseed and microbial sources
10/23/2003WO2003044217A3 Automated sample preparation methods and devices
10/23/2003WO2003040289A3 Genes coding for dna replication proteins and for proteins related to pathogenesis
10/23/2003WO2003040164A3 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/23/2003WO2003035880A3 Protein production with non-metabolizable expression inductor
10/23/2003WO2003031466A3 Angiotensin peptide-carrier conjugates and uses thereof
10/23/2003WO2003029410A3 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
10/23/2003WO2003027320A3 Methods for diagnosis and treatment of diseases associated with altered expression of pik3r1
10/23/2003WO2003025130A3 Receptors and membrane-associated proteins
10/23/2003WO2003023049A3 Methods of selecting 5'-capped nucleic acid molecules
10/23/2003WO2003023032A3 High throughput directed evolution by rational mutagenesis
10/23/2003WO2003020965A3 Use of snps of mch-r for identifying genetic disorders in maintaining the normal body weight
10/23/2003WO2003020873A3 Reproduction of ribonucleic acids
10/23/2003WO2003018775A3 Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays
10/23/2003WO2003017755A3 Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
10/23/2003WO2003016466A3 ANTI-Aβ ANTIBODIES
10/23/2003WO2003016465A3 Cell cycle regulator protein
10/23/2003WO2003014307A3 Antisense modulation of apolipoprotein(a) expression
10/23/2003WO2003011908A3 Mutant forms of the tgf-b type ii receptor which bind all tgf-b isoforms and the use thereof
10/23/2003WO2003010293A3 Maize basal layer antimicrobial protein polynucleotides and methods of use
10/23/2003WO2003010201A3 Blood group antigen fusion polypeptides and methods of use thereof
10/23/2003WO2003008576A3 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression
10/23/2003WO2003008543A3 Antisense modulation of bcl2-associated x protein expression
10/23/2003WO2003006654A3 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom
10/23/2003WO2003006622A3 Nuclear fertility restorer genes and methods of use in plants
10/23/2003WO2003000922A3 Chimeric immunomodulatory compounds and methods of using the same
10/23/2003WO2003000906A3 Plant disease resistance genes
10/23/2003WO2003000883A1 Cell proliferation inhibitors containing anti-glypican 3 antibody
10/23/2003WO2002100895A3 Antimicrobially active peptide
10/23/2003WO2002099099A3 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
10/23/2003WO2002092852A3 Method for induction of genome instability
10/23/2003WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions
10/23/2003WO2002090583A3 Skin treatment
10/23/2003WO2002088346A3 A system for inducible expression in eukaryotic cells
10/23/2003WO2002088301A3 Increased methionine in transgenic plants expressing mutant cystathionine gamma-synthase
10/23/2003WO2002081635A3 Phage display vector, phages encoded thereby, and methods of use thereof
10/23/2003WO2002081521A8 Osteoprotegerin in milk
10/23/2003WO2002081519A3 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/23/2003WO2002081518A3 Proteins, polynucleotides encoding them and methods of using the same
10/23/2003WO2002079479A3 Motor proteins and methods for their use
10/23/2003WO2002079395A3 Carotenoid biosynthesis
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002077199A3 Methods and products related to fgf dimerization
10/23/2003WO2002077163A3 Drought- and salt-resistant plants by abi5 overexpression
10/23/2003WO2002072759A3 Method to screen peptide display libraries using minicell display
10/23/2003WO2002070730A3 Models and methods for determining systemic properties of regulated reaction networks
10/23/2003WO2002070712A3 Chitin deacetylase and method for producing the same
10/23/2003WO2002070556A9 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF
10/23/2003WO2002068589A3 Enzymes having alpha amylase activity and methods of use thereof
10/23/2003WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
10/23/2003WO2002063020A3 Soybean plants with enhanced yields and methods for breeding for and screening of soybean plants with enhanced yields
10/23/2003WO2002062380A3 Chlamydia vaccine composition
10/23/2003WO2002055700A3 Human genes and gene expression products isolated from human prostate
10/23/2003WO2002048404A3 Method and kit for enhancing the association rates of polynucleotides
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
1 ... 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 ... 4023